Adial Pharmaceuticals Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
Adial Pharmaceuticals granted a new employee an inducement option to purchase 307,814 shares at $5.76 per share, matching the closing price on August 19, 2026. The option vests over four years with a 10-year term and was approved outside the company's equity incentive plans under Nasdaq Listing Rule 5635(c)(4).
Key figures
- Option shares
- 307814
- Exercise price
- 5.76
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.